TXNRD1 and cancer: Targeting the activity of the thioredoxinsystem is considered a promising strategy in cancer treatment., The resulting arylation of the TXNRD1 catalytic CysSec-dyad by thegold compound leads to potent and irreversible enzyme inhibition inhuman colon carcinoma cancer cells.